Raoul Concepcion
Urology · Nashville, TNNPI 1104801851
Payments from drug & device makers
What this record shows
This record is dominated by speaking fees: $205,380 of the $338,765 with a category attached, or 60.6%. 26 manufacturers reported payments, led by Astellas Pharma US Inc at 39.5% of the total. Reporting peaked in 2019 at $83,053 and has fallen 68.8% since, to $25,905 in 2025. Among urology clinicians in TN with any reported payments, this total sits in the top 5% — high for the specialty, which is a reason to read the composition above rather than the number alone.
Across 353 payments — averaging $959.67 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Astellas Pharma US Inc$134K
- Sun Pharmaceutical Industries Inc.$106K
- Bayer$22K
- Ferring Pharmaceuticals Inc.$14K
- Clovis Oncology, Inc.$12K
- Dendreon Pharmaceuticals LLC$8K
- plus $42K from 20 others
Across 10 payments — averaging $1122.40 each. Payments tied to a research study. These frequently flow through the physician to a hospital or research institution rather than to the physician personally.
- Bayer$7K
- Pfizer$4K
What the payments were for
- Consulting fees$73,24322%
- Speaking & faculty fees$205,38061%
- Travel & lodging$48,04714%
- Food & beverage$12,0954%
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Astellas Pharma US Inc | 97 | $133,949 |
| Sun Pharmaceutical Industries Inc. | 92 | $105,668 |
| Bayer | 38 | $21,945 |
| Ferring Pharmaceuticals Inc. | 9 | $14,446 |
| Clovis Oncology, Inc. | 22 | $12,191 |
| Dendreon Pharmaceuticals LLC | 11 | $8,385 |
| Janssen Scientific Affairs, LLC | 13 | $7,560 |
| Pfizer | 7 | $6,311 |
| Curium US LLC | 6 | $6,122 |
| Laborie Medical Technologies Corp. | 1 | $4,800 |
| Merck | 2 | $4,633 |
| Blue Earth Diagnostics | 3 | $3,974 |
| Foundation Medicine, Inc. | 3 | $3,515 |
| Sanofi | 2 | $1,699 |
| Urogen Pharma, Inc. | 12 | $1,241 |
| Johnson & Johnson | 9 | $717 |
| Sumitomo Pharma America, Inc. | 4 | $343 |
| Myovant Sciences Inc. | 4 | $305 |
| Immunitybio, Inc. | 2 | $270 |
| Roche Diagnostics Corporation | 5 | $223 |
| AstraZeneca | 2 | $193 |
| AbbVie | 4 | $106 |
| Advanced Accelerator Applications | 1 | $85 |
| Accord Healthcare, Inc. | 2 | $45 |
| Novartis | 1 | $24 |
| Clarus Therapeutics Inc. | 1 | $14 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
- XTANDI$108,103
- YONSA$95,364
- Nubeqa$14,806
- Rubraca$11,581
- FIRMAGON$8,496
- PROVENGE$8,232
- Erleada$7,732
- ODOMZO$7,691
- Xofigo$6,176
- Axumin$3,939
- FOUNDATIONACT$3,515
- FOUNDATIONFOCUS$3,515
- FOUNDATIONONE CDX$3,515
- FOUNDATIONONE HEME$3,515
- FOUNDATIONONE$3,515
- JEVTANA$1,606
- JELMYTO$762
- ORGOVYX$475
- ANKTIVA$270
- POSLUMA$114
How this compares
$338,765 in reported general payments places this provider in the 95th percentile of 276 urology providers in Tennessee.
Other urology in Nashville
- L KnollNashville$2.1M
- Gautam JayramNashville$1M
- Roger DmochowskiNashville$763K
- Ashley TapscottNashville$425K
- Melissa KaufmanNashville$312K
- Sam ChangNashville$198K
- Benjamin DehnerNashville$165K
- Smita deNashville$100K
- Nicole MillerNashville$73K
- Kelvin MosesNashville$67K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Identity: NPPES NPI Registry, July 2026.